Music Therapy in Patients With Breast Cancer (IMPACT)
NCT07549685 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2026-04-24
Summary
This study aims to evaluate the feasibility and potential benefits of music therapy in patients with breast cancer undergoing adjuvant chemotherapy.
Breast cancer patients often experience significant physical and psychological symptoms during treatment, including anxiety, fatigue and reduced quality of life. Music therapy is a promising non-pharmacological intervention that may help improve psychological well-being and symptom management. However, current evidence is mainly based on group-level studies and does not account for individual variability in response.
This pilot study is designed as a series of combined N-of-1 trials, in which each participant alternates periods with and without music therapy, acting as her own control. A total of 24 patients will be recruited from two Italian oncology centres and randomly assigned to different intervention sequences.
The intervention consists of weekly group music therapy sessions lasting approximately 60 minutes, including both active and receptive techniques, along with personalized music playlists for home use.
The primary objective is to assess the feasibility of this study design, including recruitment, retention, data completeness and acceptability of the intervention. Secondary objectives include exploring the effects of music therapy on psychological and physical well-being, as well as estimating variability in individual responses.
The results of this study will inform the design of future larger studies aimed at evaluating the effectiveness of music therapy using personalised trial approaches.
Conditions
Interventions
- OTHER
-
Music Therapy
Group sessions of music therapy last approximately 60 minutes, on a weekly basis. Sessions will include both receptive (eg guided listening and music imagery) and active techniques (eg instrumental or vocal improvisation, songwriting). All the sessions will be conducted by a qualified music therapist
Sponsors & Collaborators
-
Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di Alessandria
lead OTHER
Principal Investigators
-
Patrizia Santinon, MD · Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo - Alessandria
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-12
- Primary Completion
- 2026-03-11
- Completion
- 2026-06-30
Countries
- Italy
Study Locations
More Related Trials
-
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
NCT07513311 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients
NCT04563013 ·Status: COMPLETED ·Phase: NA
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00036998 ·Status: UNKNOWN ·Phase: PHASE2
-
Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)
NCT03255486 ·Status: COMPLETED ·Phase: NA
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer
NCT06288620 ·Status: RECRUITING ·Phase: NA
-
A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients
NCT02078531 ·Status: UNKNOWN
-
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
NCT06240195 ·Status: RECRUITING
-
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer
NCT02464774 ·Status: UNKNOWN ·Phase: NA
-
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
NCT06690645 ·Status: RECRUITING
-
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
NCT01395056 ·Status: COMPLETED
-
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NCT04925856 ·Status: RECRUITING ·Phase: NA
-
Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer
NCT03319069 ·Status: UNKNOWN ·Phase: PHASE3
-
Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer
NCT02316561 ·Status: COMPLETED ·Phase: NA
-
FMT in Triple Negative Breast Cancer Guided by ctDNA
NCT07292142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Exclusive Intraoperative Radiation Therapy for Breast Cancer
NCT01276938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
NCT00793962 ·Status: COMPLETED ·Phase: PHASE3
-
Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
NCT04805736 ·Status: COMPLETED ·Phase: PHASE2
-
Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer
NCT04803266 ·Status: UNKNOWN ·Phase: PHASE3
-
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
NCT05677802 ·Status: RECRUITING ·Phase: NA
-
Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
NCT01232062 ·Status: COMPLETED
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases
NCT07466927 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
NCT01276899 ·Status: COMPLETED